Edoardo Cignoli : Novartis Starts $5 Billion Share Buyback

Swiss pharmaceutical firm says share buyback and a new approach to acquisitions reflect a key change to the company's strategy as it conducts a sweeping review of all of its businesses.



via WSJ.com: US Business http://online.wsj.com/article/SB10001424052702304607104579213403150284332.html?mod=pls_whats_news_us_business_f